| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 表观调控组学(元) | 17,892,837.08 | 33,905,899.14 | 14,469,230.74 |
| 蛋白与代谢组学(元) | 27,005,274.31 | 52,491,833.27 | 23,125,146.50 |
| 翻译转录组学(元) | 111,798,322.51 | 236,868,000.10 | 92,405,594.66 |
| 微生物与基因组学(元) | 20,555,946.49 | 36,617,005.02 | 13,196,799.45 |
| 其他(元) | 5,983,692.69 | 6,876,834.81 | 2,628,427.02 |
| 营业成本(元) | |||
| 表观调控组学(元) | 5,904,147.86 | 10,630,491.09 | 4,749,683.04 |
| 蛋白与代谢组学(元) | 12,334,267.56 | 31,472,457.67 | 14,283,724.84 |
| 翻译转录组学(元) | 56,557,595.34 | 122,808,969.02 | 49,609,777.35 |
| 微生物与基因组学(元) | 10,564,659.38 | 18,846,937.25 | 6,630,093.46 |
| 其他(元) | 4,455,095.17 | 4,261,852.48 | 2,005,387.77 |
| 毛利(元) | |||
| 表观调控组学(元) | 11,988,689.22 | 23,275,408.05 | 9,719,547.70 |
| 蛋白与代谢组学(元) | 14,671,006.75 | 21,019,375.60 | 8,841,421.66 |
| 翻译转录组学(元) | 55,240,727.17 | 114,059,031.08 | 42,795,817.31 |
| 微生物与基因组学(元) | 9,991,287.11 | 17,770,067.77 | 6,566,705.99 |
| 其他(元) | 1,528,597.52 | 2,614,982.33 | 623,039.25 |
| 毛利率(%) | |||
| 表观调控组学(%) | 67.00 | 68.65 | 67.17 |
| 蛋白与代谢组学(%) | 54.33 | 40.04 | 38.23 |
| 翻译转录组学(%) | 49.41 | 48.15 | 46.31 |
| 微生物与基因组学(%) | 48.61 | 48.53 | 49.76 |
| 其他(%) | 25.55 | 38.03 | 23.70 |
| 收入构成(%) | |||
| 表观调控组学(%) | 9.76 | 9.24 | 9.92 |
| 蛋白与代谢组学(%) | 14.74 | 14.31 | 15.86 |
| 翻译转录组学(%) | 61.01 | 64.58 | 63.37 |
| 微生物与基因组学(%) | 11.22 | 9.98 | 9.05 |
| 其他(%) | 3.27 | 1.88 | 1.80 |
| 毛利构成(%) | |||
| 表观调控组学(%) | 12.83 | 13.02 | 14.18 |
| 蛋白与代谢组学(%) | 15.70 | 11.76 | 12.90 |
| 翻译转录组学(%) | 59.13 | 63.81 | 62.43 |
| 微生物与基因组学(%) | 10.69 | 9.94 | 9.58 |
| 其他(%) | 1.64 | 1.46 | 0.91 |